Mangia, Alessandra <br/><br/>
Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Jan 2008 
 - 43-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1527-3350 
<br/><br/><label>Standard No.: </label>10.1002/hep.22061  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--administration & dosage<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--administration & dosage<br/>Prospective Studies<br/>RNA, Viral--blood<br/>Recombinant Proteins<br/>Ribavirin--administration & dosage<br/>Treatment Outcome